518
S. A. Glover et al.
mixture with shaking followed by filtration. The filtrate was
monitored by TLC until no lactone was observed. Butyl bromide
(7.96 g, 58.1mmol) in methanol (10 mL) and sodium carbonate
(6.77 g, 63.9mmol) in water (40 mL) were added to the filtrate
and the resultant mixture was refluxed and monitored by TLC
until no further increase in non-baseline material was evident.
Excess methanol was removed under reduced pressure and the
mixture diluted with brine (50 mL). Extraction with dichloro-
methane, which was dried (anhydrous Na2SO4) and concentrated
under reduced pressure, afforded clean N-butoxy-3-hydroxybu-
tanamide (17) as a white solid (1.75 g, 9.99 mmol, 17.2 %).
Cyclisation of N-benzyloxy-2-hydroxybenzamide (19b)
N-Benzyloxy-2-hydroxybenzamide (19b) (0.24 g, l mmol)
was dissolved in 15 mL of anhydrous acetonitrile, treated with
PIFA (0.42 g, 1.5 mmol), and stirred for 5 min. NaHCO3 (10 %,
20 mL) was added with agitation for a further 3 min. The mixture
was extracted with portions of dichloromethane (2 ꢁ 20 mL),
which were washed with brine, dried over Na2SO4, and concen-
trated under reduced pressure. Purification by centrifugal
chromatography (15 % ethyl acetate/n-hexane) afforded
N-benzyloxy-3(2H)-benzisoxazolone (22b) (0.05 g, 0.2 mmol,
20 %). nmax (CHCl3)/cmꢀ1 1743 (CO). dH 7.78 (d, 1H, 4-H, 7.66
(t, 1H, 6-H), 7.51–7.54 (d, 2H, o0-H), 7.37–7.43 (m, 3H,
m0,p0-H), 7.18 (t, 1H, 5-H), 7.05 (d, 1H, 7-H) 5.31 (s, 2H). dC
173.43 (CO), 164.72 (CAr–O), 137.11 (6-C), 134.54 (C’ipso),
129.26, 128.93 (C0p), 128.58, 125.85 (4-C), 123.30 (5-C),
112.93 (C–CO), 110.64 (7-C), 79.49 (CH2). m/z (HR-ESI)
242.0815 ([MþH]þ), C14H12NO3 requires 242.0817;
264.0638 ([MþNa]þ), C14H11NO3Na requires 264.0637.
N-Butoxy-4-hydroxypentanamide (21)
Hydroxylamine hydrochloride (4.17 g, 60 mmol) in hot
methanol (30 mL) was added to potassium hydroxide (6.73 g,
120 mmol) in boiling methanol. g-Valerolactone (5 g, 50 mmol)
was added and the solution was cooled and filtered. After
standing overnight, lactone was not detected by TLC. Butyl
bromide (6.84 g, 50 mmol) was added and the reaction mixture
was stirred under reflux and monitored by TLC until no further
increase in non-baseline material was evident. Most of the
methanol was removed under reduced pressure and the mixture
diluted with brine. Extraction with dichloromethane, which was
dried (anhydrous Na2SO4) and concentrated under reduced
pressure, afforded clean N-butoxy-4-hydroxypentanamide (21)
as a yellow oil (0.729 g, 3.85 mmol, 8 %). nmax (neat)/cmꢀ1
3500ꢀ3200br (NH, OH), 1661. dH 3.85 (t, 2H, CH2–O), 3.8
(m, 1H, CH–O), 2.2–2.5 (br m, 2H, a-CH2), 1.75–1.9 (m, 1H,
b-CH), 1.65–1.75 (m, 1H, b-CH), 1.62 (quin, 2H), 1.4 (sextet,
2H), 1.2 (d, 3H), 0.95 (t, 3H). dC 171.42 (CO), 77.3(CH2–O),
67.2 (4-C), 34.07 (3-C), 29.95 (O–CH2CH2), 28.03 (2-C), 23.53
(5-C), 18.99 (CH2CH3), 13.79 (CH2CH3). m/z (ESI) 190 ([M þ
H]þ), 212 ([M þ Na]þ), 401 ([2M þ Na]þ); (HR-ESI) 190.1443
([M þ H]þ), C9H20NO3 requires 190.1443; 212.1263 ([M þ
Na]þ), C9H19NO3Na requires 212.1263.
Cyclisation of N-butoxy-3-hydroxybutanamide (17)
Treatment of N-butoxy-3-hydroxybutanamide (17) (0.027 g,
0.15 mmol) in anhydrous acetonitrile (2 mL) with an equivalent
of PIFA (0.066 g, 0.015 mmol) in anhydrous acetonitrile (2 mL)
afforded, after workup, a mixture (0.033 g) which was immedi-
ately analysed by NMR spectroscopy and was comprised mainly
of g-lactam 24 and iodobenzene (see discussion). Upon standing
overnight, 24 decomposed to a diastereomeric mixture of
hyponitrite 26. dH 5.5–5.7 (overlapping m, 2H, CH–O), 4.0–
4.15 (overlapping t, 4H, CH2–O), 3.0–3.15 (overlapping dd, 2H,
a-H1), 2.5–2.65 (overlapping dd, 2H, a-H2), 1.5–1.7 (over-
lapping quintets, 4H, O–CH2CH2), 1.4 and 1.38 (overlapping
d, 6H, CH3CH), 1.3–1.4 (overlapping sextets, 4H, CH2CH3),
0.9–0.98 (overlapping t, CH2CH3). dC 169.89 (CO), 64.80
(O–CH2), 59.90 (b-CH–O), 37.09 (a-CH2), 30.55 (CH2CH2–
O), 19.04 (CH2CH3), 16.02 (CH3CH–O), 13.64 (CH2CH3). m/z
(ESI) 347.2 ([M þ H]þ), 715.5 ([2M þ Na]þ). Purification of a
portion by centrifugal chromatography afforded clean diastero-
meric mixture 26. m/z (HR-ESI) 347.2182 ([M þ H]þ),
C16H31N2O6 requires 347.2182; 369.2002 ([M þ Na]þ),
C16H30N2O6Na requires 369.2002.
N-Butoxy-3-hydroxybutanamide (17) and PIFA in a 2 : 1
ratio were reacted in CD3CN in the probe of the NMR machine.
The reaction produced an immediate 50 : 50 mixture of
unreacted 17 and g-lactam 24 together with iodobenzene.
Compound 17: dH (CD3CN) 4.58–4.70 (ddq, J 8.9, 6.1, and
6.1, 1H, CH–O), 3.95 (t, 2H, CH2–O), 2.78 (dd, J 17.8 and 6.1, a-
H1), 2.44 (dd, J 17.8 and 8.9, a-H2), 1.59 (quin, 2H,
O–CH2CH2), 1.38 (sextet, 2H, CH2CH3), 1.37 (d, 3H, CH3CH),
0.9 (t, 3H, CH2CH3). m/z(ESI) 176 ([M þ H]þ), 198 ([M þ
Na]þ); Compound 24: dH (CD3CN) 4.0–4.15 (br m, 1H,
CH–OH), 3.83 (t, 2H, CH2–O), 2.1–2.25 (br m, 2H, a-CH2),
1.59 (quin, 2H, O–CH2CH2), 1.38 (sextet, 2H, CH2CH3), 1.15
(d, 3H, CHCH3), 0.9 (t, 3H, CH2CH3). m/z (ESI) 196
([M þ Na]þ).
PIFA Cyclisations of 17, 19, and 21
Hydroxamic esters in anhydrous acetonitrile were treated
rapidly with similar quantities of PIFA and briefly stirred. The
reaction mixture was diluted with saturated sodium carbonate.
The aqueous mixture was extracted with dichloromethane,
which was washed with brine and concentrated to afford
mixtures containing cyclised materials.
Cyclisation of N-butoxy-2-hydroxybenzamide (19a)
N-Butoxy-2-hydroxybenzamide (19a) (0.35 g, 1.7 mmol) in
50 mL of anhydrous acetonitrile was treated with PIFA (1.1 g,
2.5 mmol) and stirred for 5 min. NaHCO3 (10 %, 30 mL) was
added with agitation for a further 3 min. The mixture was
extracted with portions of dichloromethane (2 ꢁ 20 mL), which
was washed with brine, dried over Na2SO4, and concentrated
under reduced pressure. Purification by centrifugal chromatog-
raphy (15 % ethyl acetate/n-hexane) afforded N-butoxy-3(2H)-
benzisoxazolone (22a) (0.11 g, 0.5 mmol, 31.43 %). nmax
(CHCl3)/cmꢀ1 1742 (CO), 1618. dH 7.79 (d, 1H, 4-H),
7.67 (t, 1H, 6-H), 7.18 (t, 1H, 5-H), 7.06 (d, 1H, 7-H), 4.30
(t, O–CH2), 1.85 (quin, 2H, 20-CH2), 1.54 (sextet, 2H, 30-H),
0.98 (t, 3H, 40-H). dC 173.36 (CO), 164.49 (CAr–O), 137.00
(6-C), 125.82 (4-C), 123.23 (5-C), 113.06 (C–CO), 110.59
(7-C), 77.71 (10-C), 30.24 (20-C), 18.83 (30-C), 13.77 (40-C).
m/z (EI) 207, 177, 135, 121, 120, 93, 92; (HR-EI) 207.0893
(Mþ), C11H13NO3 requires 207.0895.
Cyclisation of N-butoxy-4-hydroxypentanamide (21)
Treatment of N-butoxy-4-hydroxypentanamide (21) (0.23 g,
1.2 mmol) in anhydrous acetonitrile (5 mL) with an equivalent
of PIFA (0.52 g, 1.2 mmol) in anhydrous acetonitrile (5 mL) at
room temperature afforded, after workup, a mixture (0.2 g)
which was immediately analysed by NMR spectroscopy and
was comprised mainly of d-lactam 25, g-valerolactone (27), and